News | December 12, 2022
Lupin launches generic version of Pennsaid in the US
Diclofenac Sodium Topical Solution, 2% w/w (RLD PENNSAID) had estimated annual sales of US $509 million in the US (IQVIA MAT October 2022)
Diclofenac Sodium Topical Solution, 2% w/w (RLD PENNSAID) had estimated annual sales of US $509 million in the US (IQVIA MAT October 2022)
This was a pre-approval inspection to cover our Oncology Injectable drug products for which ANDAs were filed with USFDA
Silodosin capsules treat signs and symptoms of an enlarged prostate gland
They also released the Operational Guidelines for Wellness activities at AB-HWCs
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
Company to open new headquarters in 2024
GlobalData predicts the average prices of dual chamber pacemakers in both India and China are expected to reduce at an average CAGR of -3.42% from 2022 to 2025.
Anandiben Patel, Governor, Uttar Pradesh will inaugurate the two-day celebrations
Spiro will be responsible for the overall strategy, implementation and growth of Lupin’s U.S. Generics business
35 million mosquito nets supplied to countries in sub-Saharan Africa through partners
Subscribe To Our Newsletter & Stay Updated
